Related Experiment Videos
Fenoterol effects on the in vitro immune response
G Ciprandi1, G Cipro, F Paolieri
1Allergy Centre, I.S.M.I., University of Genoa, Italy.
International Journal of Immunopharmacology
|January 1, 1988
Summary
Fenoterol, a beta-2-adrenergic agonist, did not affect key immune responses in vitro. This study found no impact on peripheral mononuclear cell proliferation or lymphokine production, unlike other tested asthma medications.
Area of Science:
- Immunology
- Pharmacology
- Respiratory Medicine
Background:
- Beta-2-adrenergic agonists are common treatments for acute bronchostenosis.
- Previous studies investigated the immune effects of cromolyn, ketotifen, and theophylline.
- Understanding fenoterol's impact on immune response is crucial for respiratory treatment.
Purpose of the Study:
- To investigate the in vitro effects of fenoterol on immune responses.
- To compare fenoterol's immunomodulatory activity with other asthma medications.
- To analyze fenoterol's impact on T-lymphocyte proliferation and lymphokine production.
Main Methods:
- Assessed mitogen (PHA)-induced proliferation of peripheral mononuclear cells (PMNC).
- Evaluated PMNC proliferation induced by anti-T3 and anti-T11 monoclonal antibodies (MAbs).
- Measured PHA-induced interleukin-2 (IL-2) and interferon-gamma (IFN-gamma) production in ten healthy volunteers at fenoterol concentrations of 2, 20, and 200 ng/ml.
Main Results:
- Fenoterol demonstrated no significant effects on PMNC proliferation.
- No alterations were observed in IL-2 and IFN-gamma production following fenoterol exposure.
- T-cell clone proliferation remained unaffected by fenoterol in vitro.
Conclusions:
- Fenoterol does not appear to modulate key in vitro immune parameters.
- These findings contrast with previous reports on the immunosuppressive effects of theophylline and ketotifen.
- Fenoterol's safety profile regarding immune function warrants further investigation in clinical settings.